Term ended no later than Oct 25, 2020 · Low confidence
20-year base term ended Aug 10, 2019
Aug 10, 1999
Oct 25, 2020
May 27, 2003
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 10, 1999, when application 09/371,747, the earliest non-provisional in its chain, was filed (this one was filed Dec 14, 2001); a parent in its chain could not be resolved (the next row) | Aug 10, 2019 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | +442 days, USPTO 35 U.S.C. 156 certificate | added to Aug 10, 2019: Oct 25, 2020 | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | no later than Oct 25, 2020 | Low confidence |
This family
| US 6,596,700 | Lapsed on the fee record Jul 2011 | Jul 2011 |
| US 6,566,344 | Term ended Aug 2019 | Aug 2019 |
| US 6,569,837 | this patent no later than Oct 2020 | no later than Oct 2020 |
| US 6,787,526 | Lapsed on the fee record Sep 2012 | Sep 2012 |
| US 6,946,450 | Term ended Aug 2019 | Aug 2019 |
| US 7,608,600 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 7,662,798 | Lapsed on the fee record Feb 2022 | Feb 2022 |
| Application 11/005,440 | Abandoned not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 3, 2002 Reel 12937, frame 346 | Centre National de la Recherche Scientifique (CNRS) | L'Universite Montpellier II (Umii) | Assignment of Assignor's Interest |
| Aug 19, 2002 Reel 13193, frame 841 | Novirio Pharmaceuticals Limited | Idenix Pharmaceuticals Inc. | Change of Name |
| Feb 6, 2003 Reel 13718, frame 543 | Novirio Pharmaceuticals Limited | Idenix Pharmaceuticals Inc. | Certicate of Domestication Incorporation in Delaware |
| Mar 26, 2014 Reel 32535, frame 402 | Idenix Pharmaceuticals, Inc. | Novartis AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Oct 25, 2020. We will not guess the cap.